T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands. (Q38996151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Pinar Karasar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

English

0 references

publication date

10 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

605-614

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

Cancer despite immunosurveillance: immunoselection and immunosubversion

18 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Triple-negative/basal-like breast cancer: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Cutting Edge: Murine Vascular Endothelium Activates and Induces the Generation of Allogeneic CD4+25+Foxp3+ Regulatory T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Myeloid leukemia cells with a B7-2(+) subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Immune compartmentalization of T cell subsets in chemically-induced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

In situ cytokine production by breast cancer tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

PD-L1 expression is increased in a subset of basal type breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2984-9

10.1007/S10549-014-2984-9

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

18 March 2020

1051362501

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24816762%20AND%20SRC:MED&resulttype=core&format=json